Biogen Inc (NASDAQ:BIIB) stock had a fantastic start to September with a 15% rally. But in the past few days of trading, it gave back about one-third of it. Source: Biogen via YouTube Clearly, this is a momentum stock, so it will never give …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
The share price of Biogen Inc. (NASDAQ:BIIB) tumbled as much as 8 percent, to $395, Friday after sales of the …
There are times when a negative piece of news in the BioPharma sector can actually help rival companies. Biogen Inc. (NASDAQ: BIIB) is a stock that has been battered of late, and it is a key company in the treatment for multiple …
The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center are highlighting two trades on Biogen Idec (BIIB) today after it ... as long as the stock closes above $315 at expiration.
12/22 $CS SEES WRITE-DOWN OF ABOUT CHF 2.3B ON TAX REFORM once worked at CSFB i t.. 12/22 BRIEF-Credit Suisse Says it Expects Write-Down Of about Chf 2.3 bln In Q4 201.. 12/22 Credit Suisse : US Tax Cuts and Jobs Act …
The current valuation of Biogen Inc’s (NASDAQ: BIIB) stock represents “a reasonable entry for the Alzheimer's and SMA franchises as well as a couple of other pipeline programs that seem interesting,” Piper Jaffray’s Joshua E. Schimmer …
Key highlights this week include the announcement of a couple of acquisition agreements as well as pipeline news from …
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here. Biogen (NASDAQ: BIIB) announced that its Board of Directors authorized a program to repurchase up to $5 billion of the …